Abstract
Galectin-3 (Gal-3) has been suggested to have both pro- and anti-atherogenic properties. High plasma Gal-3 levels are associated with increased risk for cardiovascular (CV) death. However, it has so far not been investigated if plasma Gal-3 levels can predict the risk for future stroke in patients suffering from carotid atherosclerosis. The aim of this study was to investigate whether Gal-3 could be used as a marker to predict postoperative cerebrovascular ischemic events among patients who underwent carotid endarterectomy (CEA).
Original language | English |
---|---|
Pages (from-to) | 199-203 |
Journal | Cerebrovascular Diseases |
Volume | 41 |
Issue number | 3-4 |
DOIs | |
Publication status | Published - 2016 |
Subject classification (UKÄ)
- Cardiac and Cardiovascular Systems